{
    "title": "No preferential access to Themis' potential COVID-19 vaccine -CEO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8365323/No-preferential-access-Themis-potential-COVID-19-vaccine-CEO.html",
    "date": "2020-05-28",
    "keywords": [
        "vaccine",
        "covid19",
        "themis",
        "merck",
        "virus",
        "bioscience",
        "thursday",
        "past",
        "coronavirus",
        "disease",
        "respiratory",
        "syndrome",
        "ceo",
        "approval",
        "nobody",
        "access",
        "drug",
        "maker",
        "executive",
        "anybody",
        "tauber",
        "race",
        "tuesday",
        "collaboration",
        "pasteur",
        "paris",
        "world",
        "way",
        "vaccination",
        "relationship",
        "help",
        "development",
        "process",
        "lot",
        "sarscov2",
        "body",
        "france",
        "america",
        "vector",
        "system",
        "company",
        "staff",
        "phase",
        "iii",
        "study",
        "chikungunta",
        "focus",
        "antibody",
        "response",
        "spread",
        "half",
        "year",
        "contact",
        "europe",
        "priority",
        "manufacturing",
        "network",
        "advantage",
        "kirsti",
        "jason"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}